An engineered bacterium containing acyl-CoA oxidase gene and its application in preparing 10-hydroxy-2-decenoic acid

By constructing engineered bacteria containing the fatty acyl-CoA oxidase gene, the synthesis pathway of 10-hydroxy-2-decenoic acid was optimized, and the problems of low yield and harsh production conditions in the existing technology were solved, achieving high efficiency and low cost Industrial production of 10-hydroxy-2-decenoic acid.

CN115806923BActive Publication Date: 2024-11-15QILU UNIVERSITY OF TECHNOLOGY (SHANDONG ACADEMY OF SCIENCES)
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202211249293.8
Authority / Receiving Office
CN · China
Patent Type
Patents(China)
Current Assignee / Owner
Filing Date
2022-10-12
Publication Date
2024-11-15
Estimated Expiration
2042-10-12

AI Technical Summary

Technical Problem

When obtaining 10-hydroxy-2-decenoic acid, the prior art has problems with low yield, harsh production conditions, high pollution risk and cis-trans isomerization, and the biosynthesis pathway is not perfect enough, making it difficult to meet the needs of industrial production.

Method used

Constructing engineered bacteria containing the fatty acyl Coenzyme A oxidase gene, and perform a step by transducing the fatty acyl Coenzyme A thioesterase gene into E. coli or Saccharomyces cerevisiae. 10-hydroxy-2-decenoic acid was prepared by reaction, and the synthesis pathway and conversion conditions were optimized to improve conversion.

Benefits of technology

It significantly improved the conversion rate of 10-hydroxy-2-decenoic acid, especially the conversion rate of E. coli genetically engineered bacteria reached 85% to 92%, making the industrial production of 10-hydroxy-2-decenoic acid possible, achieving Efficient and low-cost production.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure BDA0003887283730000011
    Figure BDA0003887283730000011
  • Figure BDA0003887283730000091
    Figure BDA0003887283730000091
  • Figure BDA0003887283730000121
    Figure BDA0003887283730000121
Patent Text Reader

Abstract

The present invention relates to an engineered bacterium containing an acyl-CoA oxidase gene and an application thereof in preparing 10-hydroxy-2-decenoic acid, and belongs to the technical field of microbial fermentation. The engineered bacterium containing an acyl-CoA oxidase gene of the present invention includes an acyl-CoA oxidase gene and an acyl-CoA thioesterase gene, and the acyl-CoA oxidase gene is derived from tropical Candida or Yarrowia lipolytica. The present invention adopts acyl-CoA oxidase from tropical Candida and Yarrowia lipolytica, combined with existing acyl-CoA thioesterase, to jointly convert 10-hydroxydecanoic acid, significantly improve the conversion rate of 10-hydroxy-2-decenoic acid, and realize the process of producing high value-added 10-hydroxy-2-decenoic acid with low-value 10-hydroxydecanoic acid.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention relates to an engineering bacterium containing an acyl-CoA oxidase gene and application of the engineering bacterium in preparing 10-hydroxy-2-decenoic acid, belonging to the technical field of microbial fermentation. Background Art

[0002] 10-Hydroxy-2-decenoic acid (10-HDA) is a quality indicator of royal jelly, and has various excellent properties such as antibacterial, lowering blood sugar, and improving immunity. In recent years, people's living standards have continued to improve, and they have paid more attention to personal health and related health industries, and have paid more and more attention to 10-HDA with multiple physiological activities. The structure of the compound is as follows:

[0003]

[0004] So far, the main methods for obtaining 10-HDA are extraction, chemical synthesis, and microbial fermentation. There are many extraction methods, including ether extraction, ethanol extraction, etc. However, the content of 10-HDA in royal jelly is low, which is difficult to meet the wide market demand, and the extraction cost is high. Since the 1960s, a variety of chemical synthesis methods of 10-HDA have been designed and applied to production, such as the Doebmer condensation method, the substrate of which is 1,6-hexanediol, and the yield is 61%; the condensation method, which uses γ-bromobutyl ester Grignard and organic magnesium compounds as substrates, and condenses the two to generate 10-HDA, and the yield of this method reaches 70%. All of the above experimental methods can obtain 10-HDA, but the chemical synthesis method has inevitable disadvantages, such as: harsh production conditions, easy to cause pollution, etc., and the raw materials are not easy to obtain, the synthesis route is long, the yield is low, and the chemical synthesis has the problem of cis-trans isomerism, and the product is poor in singleness. Therefore, the production of 10-HDA based on biosynthesis has become a new research direction.

[0005] Chinese patent document CN 109402182 A (application number 201811126048.1) discloses a method for preparing 10-hydroxy-2-decenoic acid using resting cells of Escherichia coli engineered bacteria, the steps of which are as follows: (1) constructing Escherichia coli engineered bacteria containing the recombinant plasmid pET-28a-ydiI; (2) taking the Escherichia coli engineered bacteria containing the recombinant plasmid pET-28a-ydiI to prepare induced cells; (3) culturing the induced cells with a transformation medium to obtain resting cells, and then adding 10-hydroxydecanoic acid to the medium to prepare 10-hydroxy-2-decenoic acid. The synthesis pathway of 10-hydroxy-2-decenoic acid in the patent document: using 10-hydroxydecanoic acid as a reaction substrate, relying on the first two steps of β-oxidation, after forming a trans double bond, the Escherichia coli acyl-CoA thioesterase ydiI hydrolyzes CoA to release 10-hydroxy-2-decenoic acid.

[0006] Chinese patent document CN 109897870 A (application number 201910088897.0) discloses a method for preparing 10-hydroxy-2-decenoic acid using decanoic acid as a raw material using Escherichia coli engineered bacteria, the steps of which are as follows: (1) constructing a recombinant plasmid pBbB5K-P450 fusion enzyme, a recombinant plasmid pBbB5K-FadK, a recombinant plasmid pBbB5K-MCAD, and a recombinant plasmid pBbB5K-YdiI; (2) constructing a pBbB5K-ydiI-MCAD-FadK-P450 fusion enzyme combination plasmid; (3) transforming the fusion enzyme combination plasmid into Escherichia coli, screening, inducing and culturing to obtain induced cells; (4) culturing the induced cells in a transformation medium to obtain resting cells, and then adding decanoic acid to the medium and culturing to obtain 10-hydroxy-2-decenoic acid. The synthesis pathway of 10-hydroxy-2-decenoic acid in the patent document is as follows: 10-HDA is produced by a two-step process using the substrate decanoic acid. The first step is a reaction from decanoic acid to trans-2-decenoic acid. Decanoic acid is added with coenzyme A under the action of acyl-CoA synthetase FadK to form decanoyl-CoA. Then, decanoyl-CoA removes two hydrogen atoms at the ortho position (β-position) of the carboxyl group of decanoyl-CoA under the action of acyl-CoA dehydrogenase MCAD to convert it into trans-decenoyl-CoA. Finally, trans-decenoyl-CoA removes coenzyme A under the action of acyl-CoA thioesterase YdiI to form trans-2-decenoic acid. The second step is the terminal hydroxylation of trans-2-decenoic acid under the action of P450 fusion enzyme to form 10-hydroxy-2-decenoic acid.

[0007] Chinese patent document CN 113106109 A (application number 202110211118.9) discloses a mutant enzyme CYP153A M228L and its application in the synthesis of 10-hydroxy-2-decenoic acid. The specific mutant enzyme CYP153A M228L is a method in which the amino acid at position 228 of the CYP153A enzyme is mutated from M to L; a two-step biosynthesis method of 10-hydroxy-2-decenoic acid using decanoic acid as a raw material mainly includes constructing an optimized recombinant plasmid pCDFDuet-1-MaMACS-PpFadE and an optimized recombinant plasmid pET21b-CYP153A M228L-CPR BM3, optimized recombinant plasmid pET28a-SUMO-ctYdiI; constructed recombinant Escherichia coli to obtain resting cells, which were further cultured to obtain 10-hydroxy-2-decenoic acid. This patent document is optimized on the basis of patent document CN109897870 A (application number 201910088897.0), and 10-HDA is generated by a two-step method. The acyl-CoA dehydrogenase gene PpFadE, acyl-CoA synthetase gene MaMACS, and acyl-CoA thioesterase gene ctydiI are not the same genes as the acyl-CoA dehydrogenase gene MCAD, acyl-CoA synthetase gene FadK, and acyl-CoA thioesterase gene ydiI in Chinese patent document CN109897870A (application number: 201910088897.0). The alkane hydroxylase CYP153A changes the amino acid at position 228 from M to L, and the conversion rate of 10-hydroxy-2-decenoic acid is increased to 54.6%.

[0008] It is still necessary to develop more diverse synthetic pathways for 10-hydroxy-2-decenoic acid for the industrial production of 10-hydroxy-2-decenoic acid. Summary of the invention

[0009] In view of the deficiencies of the prior art, the present invention provides an engineering bacterium containing an acyl-CoA oxidase gene, and utilizes the engineering bacterium to prepare 10-hydroxy-2-decenoic acid by a one-step reaction with 10-hydroxydecanoic acid as a substrate.

[0010] On the basis of previous research, the present invention further constructs expression elements, improves key enzymes in the 10-hydroxy-2-decenoic acid synthesis pathway, and provides a method for preparing 10-hydroxy-2-decenoic acid by one-step reaction using genetically engineered bacteria with 10-hydroxydecanoic acid as a substrate.

[0011] Terminology Note:

[0012] Acyl-CoA oxidase: acyl-CoA oxidase, abbreviated as ACO.

[0013] Acyl-CoA thioeaterase: acyl-CoA thioeaterase, abbreviated as ACOT.

[0014] The technical solution of the present invention is as follows:

[0015] An engineered bacterium containing a fatty acyl-CoA oxidase gene, wherein the engineered bacterium comprises a fatty acyl-CoA oxidase gene and a fatty acyl-CoA thioesterase gene.

[0016] Preferably according to the present invention, the acyl-CoA oxidase gene is derived from Candida tropicalis or Yarrowia lipolytica, and its nucleotide sequence is SEQ ID NO.1, SEQ ID NO.2, SEQ ID NO.3 or SEQ ID NO.4; the nucleotide sequence of the acyl-CoA thioesterase gene is SEQ ID NO.5.

[0017] Further preferably, the nucleotide sequence of the acyl-CoA oxidase gene is SEQ ID NO.1 or SEQ ID NO.3.

[0018] Further preferably, the amino acid sequence of the acyl-CoA oxidase is SEQ ID NO.6, SEQ ID NO.7, SEQ ID NO.8 or SEQ ID NO.9, and the amino acid sequence of the acyl-CoA thioesterase is SEQ ID NO.10.

[0019] Preferably according to the present invention, the host bacteria of the genetically engineered bacteria is Escherichia coli or Saccharomyces cerevisiae.

[0020] The method for constructing the above-mentioned engineered bacteria containing the acyl-CoA oxidase gene comprises the following steps:

[0021] (1) Construction of recombinant plasmids pETDuet-1-ACO, pET28a-SUMO-ACOT, and pESC-URA-SUMO-ACOT;

[0022] The nucleotide sequence of the acyl-CoA oxidase ACO gene is shown in SEQ ID NO.1, SEQ ID NO.2, SEQ ID NO.3 or SEQ ID NO.4, and the nucleotide sequence of the acyl-CoA thioesterase ACOT gene is shown in SEQ ID NO.5;

[0023] (2) The recombinant plasmid pETDuet-1-ACO and pET28a-SUMO-ACOT of step (1) are co-transformed into Escherichia coli, and after screening and identification, a genetically engineered Escherichia coli bacterium is obtained; the recombinant plasmid pETDuet-1-ACO and pESC-URA-SUMO-ACOT of step (1) are co-transformed into Saccharomyces cerevisiae, and after screening and identification, a genetically engineered Saccharomyces cerevisiae bacterium is obtained.

[0024] The engineering bacteria containing the acyl-CoA oxidase gene is used in preparing 10-hydroxy-2-decenoic acid using 10-hydroxydecanoic acid as a substrate.

[0025] A preferred technical solution of the present invention is a method for preparing 10-hydroxy-2-decenoic acid using the above-mentioned engineered bacteria containing the acyl-CoA oxidase gene and 10-hydroxydecanoic acid as a substrate, the steps of which are as follows:

[0026] The genetically engineered Escherichia coli constructed above was induced to obtain induced cells, the induced cells were inoculated into a transformation medium, 10-hydroxydecanoic acid was added, and 10-hydroxy-2-decenoic acid was obtained by fermentation at 37°C.

[0027] According to the preferred embodiment of the present invention, the induction culture is as follows: the genetically engineered Escherichia coli is inoculated into a liquid LB medium containing 50 μg / mL kanamycin and 40 μg / mL streptomycin, and cultured at 37°C with shaking until the bacterial solution OD reaches 600 The concentration of IPTG was 0.5 mM, and the induction culture was continued for 20 to 25 hours. The cells were separated to obtain induced cells.

[0028] Further preferably, the cells are separated by centrifugation at 5000 rpm for 15 min, the cell precipitate is collected, and then the cell precipitate is washed with 100 mM PBS buffer at pH 7.2-7.4.

[0029] Preferably, according to the present invention, the components of the transformation medium are as follows, all in mass percentage:

[0030] Glycerol 1%, glucose 0.4%, kanamycin 50 μg / mL, streptomycin 40 μg / mL, and the balance is 100 mM potassium phosphate buffer at pH 7.4.

[0031] Preferably according to the present invention, 10-hydroxydecanoic acid is added to a concentration of 0.1 g / L.

[0032] Preferably according to the present invention, 10-hydroxydecanoic acid is dissolved in dimethyl sulfoxide and then added to the transformation medium.

[0033] A preferred technical solution of the present invention is a method for preparing 10-hydroxy-2-decenoic acid using the above-mentioned engineered bacteria containing the acyl-CoA oxidase gene and 10-hydroxydecanoic acid as a substrate, the steps of which are as follows:

[0034] The genetically engineered yeast of Saccharomyces cerevisiae constructed above was induced to obtain induced cells, which were inoculated into a transformation medium, and 10-hydroxydecanoic acid was added, and fermented at 30° C. to obtain 10-hydroxy-2-decenoic acid.

[0035] According to the preferred embodiment of the present invention, the induction culture is as follows: the genetically engineered yeast of Saccharomyces cerevisiae is inoculated into a liquid YPD medium containing 100 μg / mL ampicillin and 40 μg / mL streptomycin, and the culture is performed at 30°C with shaking screening until the bacterial solution OD is 600The concentration of galactose is 0.8-1.2, and the temperature is lowered to 16-20°C for 1 hour, and then 2% galactose is added. The induction culture is continued for 48-55 hours, and the cells are separated to obtain induced cells.

[0036] Further preferably, the cells are separated by centrifugation at 5000 rpm for 15 min, the cell precipitate is collected, and then the cell precipitate is washed with 100 mM PBS buffer at pH 7.2-7.4.

[0037] Preferably, according to the present invention, the components of the transformation medium are as follows, all in mass percentage:

[0038] Glycerol 1%, glucose 0.4%, ampicillin 100 μg / mL, streptomycin 40 μg / mL, and the balance is 100 mM potassium phosphate buffer at pH 7.4.

[0039] Preferably according to the present invention, 10-hydroxydecanoic acid is added to a concentration of 0.1 g / L.

[0040] Preferably according to the present invention, 10-hydroxydecanoic acid is dissolved in dimethyl sulfoxide and then added to the transformation medium.

[0041] The steps not described in detail in the present invention are all performed according to conventional operations in the art.

[0042] Beneficial effects:

[0043] 1. The present invention integrates the key enzymes for the biosynthesis of 10-hydroxy-2-decenoic acid, and co-transfers the acyl-CoA oxidase gene and the acyl-CoA thioesterase gene into the host bacteria to achieve efficient expression of the 10-hydroxy-2-decenoic acid expression element, and after induction culture, 10-hydroxy-2-decenoic acid can be produced in a one-step fermentation process using 10-hydroxydecanoic acid as a substrate in the form of resting cells, thereby achieving the process of producing high-value-added 10-hydroxy-2-decenoic acid from low-value 10-hydroxydecanoic acid.

[0044] 2. The present invention optimizes the synthesis pathway of 10-hydroxy-2-decenoic acid and the relevant conditions in the conversion process. The present invention has found through preliminary experiments that not all microorganisms contain the synthesis pathway from 10-hydroxydecanoic acid to 10-hydroxy-2-decenoic acid. After further optimization, acyl-CoA oxidase from Candida tropicalis and Yarrowia lipolytica is used in combination with existing acyl-CoA thioesterase to jointly convert 10-hydroxydecanoic acid, significantly improving the conversion rate of 10-hydroxy-2-decenoic acid, especially the constructed Escherichia coli genetically engineered bacteria (BL21) / pETDuet-1- Ct ACO2, pET28a-SUMO-YdiI and (BL21) / pETDuet-1- CtACO5, pET28a-SUMO-YdiI, the conversion rates were 85% and 92% respectively, and the constructed Saccharomyces cerevisiae genetic engineering strain Sc. / pETDuet-1- Ct ACO2, pESC-URA-SUMO-YdiI and Sc. / pETDuet-1- Ct The conversion rates of ACO5 and pESC-URA-SUMO-YdiI both reached 82%, which was significantly improved, making the industrial production of 10-hydroxy-2-decenoic acid possible. BRIEF DESCRIPTION OF THE DRAWINGS

[0045] Figure 1 This is a graph showing the changes in the consumption of 10-hydroxydecanoic acid substrate by different strains in Example 1.

[0046] Figure 2 For the recombinant plasmid pETDuet-1- Ct Schematic diagram of the structure of ACO5;

[0047] Figure 3 The agarose gel electrophoresis diagram of the PCR product of the ACO gene on the pETDuet-1 plasmid in the recombinant bacteria in Example 3, wherein lane M is a marker and lane 1 is Ct ACO2,2 is Ct ACO4,3 Ct ACO5,4 Yl ACO;

[0048] Figure 4 is the SDS-PAGE image of the recombinant bacteria induced product, M is a marker, 1 is the recombinant bacteria (BL21) / pETDuet-1- Ct ACO2, pET28a-SUMO-YdiI, 2 for recombinant bacteria (BL21) / pETDuet-1- Ct ACO4, pET28a-SUMO-YdiI, 3 are recombinant bacteria (BL21) / pETDuet-1- Ct ACO5, pET28a-SUMO-YdiI, 4 are recombinant bacteria (BL21) / pETDuet-1- Yl ACO2, pET28a-SUMO-YdiI, where the target protein acyl-CoA thioesterase YdiI is 15 kDa, acyl-CoA oxidase Ct ACO2 is 78 kDa, acyl-CoA oxidase Ct ACO4 is 79 kDa, acyl-CoA oxidase Ct ACO5 is 74 kDa, acyl-CoA oxidase YlThe size of ACO is 78 kDa;

[0049] Figure 5 This is the mass spectrum of the fermentation product 10-hydroxy-2-decenoic acid.

[0050] Figure 6 This is a graph showing the yield changes of 10-hydroxy-2-decenoic acid, a product of the fermentation of genetically engineered bacteria in Example 5. DETAILED DESCRIPTION

[0051] The technical scheme of the present invention is further described below in conjunction with the embodiments, but the protection scope of the present invention is not limited thereto. The operating methods not described in detail in the embodiments are all conventional operating methods known to those skilled in the art.

[0052] Sources of biological materials:

[0053] Acyl-CoA oxidase Ct ACO2 gene: derived from Candida tropicalis MYA-3404, Genbank Accession No. XM_002548031.1, the nucleotide sequence is SEQ ID NO.1, and the encoded amino acid sequence is SEQ ID NO.6.

[0054] Acyl-CoA oxidase Ct ACO4 gene: derived from Candida tropicalis strain MYA-3404, Genbank Accession No: CP047872.1; its nucleotide sequence is SEQ ID NO.2, and the encoded amino acid sequence is SEQ ID NO.7.

[0055] Acyl-CoA oxidase Ct ACO5 gene: derived from Candida tropicalis strain MYA-3404, Genbank Accession No: CP047872.1; its nucleotide sequence is SEQ ID NO.3, and the encoded amino acid sequence is SEQ ID NO.8.

[0056] Acyl-CoA oxidase Yl ACO gene: derived from Yarrowia lipolytica strain W29, Genbank Accession No: CP028451.1; its nucleotide sequence is SEQ ID NO.4, and the encoded amino acid sequence is SEQ ID NO.9.

[0057] The acyl-CoA thioesterase YdiI gene is recorded in Chinese patent document CN 113106109 A (application number 202110211118.9), its nucleotide sequence is SEQ ID NO.5, and the encoded amino acid sequence is SEQ ID NO.10.

[0058] The reagents and drugs used in the present invention are all common commercially available products.

[0059] Example 1: Verification of 10-hydroxydecanoic acid metabolism by different strains:

[0060] By testing the fermentation of 10-hydroxydecanoic acid substrate on different strains such as Candida tropicalis, Escherichia coli, Staphylococcus aureus, Corynebacterium glutamicum, Bacillus subtilis, Yarrowia lipolytica, and Saccharomyces cerevisiae, it was found that Candida tropicalis and Yarrowia lipolytica have the ability to metabolize 10-hydroxydecanoic acid to synthesize 10-hydroxy-2-decenoic acid. The specific steps are as follows:

[0061] (1) Activation of strains: Different strains were inoculated into 50 mL of liquid culture medium at a 1% inoculum for activation. The culture conditions were as follows:

[0062] Candida tropicalis: YPD medium, 30°C, 200 rpm shaking culture for 48 h,

[0063] Escherichia coli: LB medium, 37°C, 200 rpm shaking culture for 48 h,

[0064] Staphylococcus aureus: LB medium, 37°C, 200 rpm shaking culture for 48 h,

[0065] Corynebacterium glutamicum: LB medium, 37°C, 200 rpm shaking culture for 48 h,

[0066] Bacillus subtilis: LB medium, 37°C, 200 rpm shaking culture for 48 h,

[0067] Yarrowia lipolytica: YPD medium, 30°C, 200 rpm shaking culture for 48 h,

[0068] Saccharomyces cerevisiae: YPD medium, 30°C, 200 rpm shaking culture for 48 h,

[0069] The components of the culture medium include the following, all in mass percentage:

[0070] LB medium: 0.5% yeast extract, 1% peptone, 1% NaCl, pH adjusted to 7.0 with NaOH,

[0071] YPD medium: 1% yeast extract powder, 2% peptone, 2% glucose;

[0072] (2) Bacterial transfer: Take 1 mL of the activated strain bacterial solution and inoculate it into 50 mL of liquid culture medium. The culture conditions are the same as those for the activation of the strain. Cultivate the bacterial solution until the OD 600 After acclimation to 0.8, the temperature was lowered to 16°C for 1 hour, and IPTG was added to make the IPTG concentration in the culture medium 0.5 mM. The culture was cultured at 200 rpm for 20 hours according to the culture temperature during activation.

[0073] (3) Collecting bacteria: Take 50 mL of the above bacterial solution and centrifuge at 5000 rpm and 4°C for 15 min to collect the bacteria;

[0074] (4) Wash the precipitate three times with 100 mM PBS buffer (pH 7.2-7.4), and resuspend the bacteria with transformation medium, wherein the transformation medium contains 1% glycerol, 0.4% glucose, and the remainder is 100 mM potassium phosphate buffer at a pH of 7.4. 10-hydroxydecanoic acid is added to make the concentration of 10-hydroxydecanoic acid in the culture medium 0.1 g / L, and the reaction is carried out at 200 rpm for 48 hours at the activation temperature to obtain a fermentation broth.

[0075] Silanization treatment of fermentation broth: take 1 mL of fermentation broth into a 2 mL centrifuge tube, add 1 mL of 4 M HCl solution, vortex centrifuge, heat at 100 ° C for 10 min, and then refrigerate at -80 ° C for 15 min. After melting at room temperature, add 1 mL of ethyl acetate and vortex centrifuge. Collect the organic phase into a new tube, add 100 μL of N, O-bis (trimethylsilyl) trifluoroacetamide and shake to mix. After 70 ° C water bath for 40 min, set aside.

[0076] Gas chromatography-mass spectrometry was used to detect the generated products and substrate consumption: the gas chromatography used nitrogen as the carrier gas, constant flow mode, an injection volume of 1 μL, split injection, a split ratio of 1:50, an injection temperature of 250 °C, maintained at 50 °C for 1 min, increased to 250 °C at 15 °C / min, and maintained for 10 min.

[0077] During the fermentation process, the content of 10-hydroxydecanoic acid in the fermentation broth of the strain changes as follows: Figure 1 As shown, the consumption rate of 10-hydroxydecanoic acid by different strains was calculated, and the calculation results are as follows:

[0078] Table 1: Consumption rate of 10-hydroxydecanoic acid by different strains

[0079] strains Consumption rate Candida tropicalis 100% Escherichia coli 2% Staphylococcus aureus 1% Corynebacterium glutamicum 1% Bacillus subtilis 1% Yarrowia lipolytica 100% Saccharomyces cerevisiae 7%

[0080] It can be seen from the data in the above table that after 48 hours of reaction, the consumption rate of 10-hydroxydecanoic acid by Candida tropicalis and Yarrowia lipolytica is 100%, while Escherichia coli, Staphylococcus aureus, Corynebacterium glutamicum, Bacillus subtilis and Saccharomyces cerevisiae can basically not consume 10-hydroxydecanoic acid.

[0081] The synthesis pathway of 10-hydroxy-2-decenoic acid disclosed in the prior art is: the substrate decanoic acid is first reacted to generate trans-2-decenoic acid, and trans-2-decenoic acid is then terminally hydroxylated to form 10-hydroxy-2-decenoic acid, such as Chinese patent document CN109897870 A (application number 201910088897.0) and Chinese patent document CN 113106109 A (application number 202110211118.9). In the process of research, the present invention also constructed another synthesis pathway of 10-hydroxy-2-decenoic acid, firstly terminally hydroxylating the substrate decanoic acid to generate 10-hydroxydecanoic acid, and then β-oxidizing 10-hydroxydecanoic acid to generate 10-hydroxy-2-decenoic acid. However, it was found in the previous studies that in this synthetic pathway, after generating 10-hydroxydecanoic acid, the reaction activity of generating 10-hydroxy-2-decenoic acid from 10-hydroxydecanoic acid is weak, resulting in the accumulation of a large number of intermediate products 10-hydroxydecanoic acid, and generating 10-hydroxy-2-decenoic acid from 10-hydroxydecanoic acid is the rate-limiting step of this synthetic pathway. In the technical scheme of Chinese patent document CN 109402182 A (application number 201811126048.1), 10-hydroxydecanoic acid is used as a substrate to produce 10-hydroxy-2-decenoic acid, and the unstable phenomenon of product sometimes appears. The present invention finds through the above experiments that not all strains can metabolize 10-hydroxydecanoic acid to generate 10-hydroxy-2-decenoic acid, and the enzyme on the β-oxidation pathway may be the key factor affecting the generation of 10-hydroxydecanoic acid from 10-hydroxydecanoic acid.

[0082] Example 2: Construction of recombinant plasmid

[0083] Recombinant plasmid pETDuet-1- Ct ACO2, pETDuet-1- Ct ACO4, pETDuet-1- Ct ACO5, pETDuet-1- Yl Synthesis of ACO, pET28a-SUMO-YdiI, and pESC-URA-SUMO-YdiI:

[0084] Acyl-CoA oxidase Ct ACO2, Ct ACO4, Ct ACO5, Yl The nucleotide sequences of the ACO gene are shown in SEQ ID NO.1, SEQ ID NO.2, SEQ ID NO.3 and SEQ ID NO.4 respectively, the nucleotide sequence of the acyl-CoA thioesterase YdiI gene is shown in SEQ ID NO.5; and the acyl-CoA oxidase Ct ACO2, Ct ACO4, CtACO5, Yl The amino acid sequences of the proteins encoded by the ACO gene are shown in SEQ ID NO.6, SEQ ID NO.7, SEQ ID NO.8, and SEQ ID NO.9, respectively, and the amino acid sequence of the protein encoded by the acyl-CoA thioesterase YdiI gene is shown in SEQ ID NO.10;

[0085] The recombinant plasmid pETDuet-1- Ct ACO2, pETDuet-1- Ct ACO4, pETDuet-1- Ct ACO5, pETDuet-1- Yl ACO, pET28a-SUMO-YdiI, and pESC-URA-SUMO-YdiI were all produced by Nanjing GenScript Biotechnology Co., Ltd. Among them, the constructed recombinant plasmid pETDuet-1- Ct The structural diagram of ACO5 is shown in Figure 2 shown.

[0086] Example 3: Construction of genetically engineered Escherichia coli

[0087] (1) Preparation of E. coli competent cells

[0088] ① Pick a single colony of E. coli BL21 (or pick a preserved strain) and inoculate it into 50 mL of liquid LB medium, and culture it overnight at 37°C and 200 rpm;

[0089] ②Take 1mL of E. coli culture and inoculate it into 50mL of liquid LB medium. Cultivate at 37℃ and 200rpm until the OD value of the culture solution reaches 600 About 0.5-0.6;

[0090] ③ Place the bacterial solution on the ice-water mixture for 10 minutes and pre-cool the 50mL centrifuge tube;

[0091] ④ Transfer the bacterial solution to a centrifuge tube and centrifuge at 3700 rpm for 10 min at 4°C to collect the bacteria;

[0092] ⑤ Add 10 mL of pre-cooled 0.1 M CaCl2 solution to each centrifuge tube, resuspend the bacteria, then add 30 mL of pre-cooled 0.1 M CaCl2 solution, invert to mix, and let stand on ice for 20 min;

[0093] ⑥Centrifuge at 4°C, 3700 rpm for 10 min to collect the cells, add pre-cooled 0.1 M CaCl2 solution containing 15% glycerol at a volume ratio of 3:125 to the bacterial solution in step ④, resuspend the cells to obtain competent cells;

[0094] ⑦ Aliquot the competent cells and freeze at -80℃.

[0095] (2) Transformation of recombinant plasmids in E. coli

[0096] ① Recombinant plasmid pETDuet-1- Ct ACO2 and pET28a-SUMO-YdiI are one group, pETDuet-1- Ct ACO4 and pET28a-SUMO-YdiI are one group, pETDuet-1- Ct ACO5 and pET28a-SUMO-YdiI are one group, pETDuet-1- Yl ACO and pET28a-SUMO-YdiI were grouped together. The volume ratio of the two plasmids in each group was 1:1, and a total of 10 μL was added to 100 μL of freshly prepared competent cells, mixed gently, and placed on ice for 30 min.

[0097] ②Heat shock at 42℃ for 90s, then quickly cool in an ice bath for 3min;

[0098] ③ Add 900 μL LB medium and culture at 37°C with shaking at 200 rpm for 60 min;

[0099] ④ Centrifuge at 3700 rpm for 10 min to collect the cells, discard the supernatant, and resuspend the precipitate in 100 μL of liquid LB medium;

[0100] ⑤ Take 100 μL of the above bacterial solution and spread the E. coli bacterial solution on LB solid medium with 50 μg / mL kanamycin and 40 μg / mL streptomycin;

[0101] ⑥ Place the LB solid culture medium upright in a 37℃ incubator for 30 minutes. After the bacterial liquid is absorbed dry, invert the plate and incubate at 37℃ for 12-16 hours.

[0102] (3) Identification of positive clones:

[0103] ① Colony PCR identification

[0104] Pick the single colony cultured above, inoculate the E. coli into 1 mL of LB medium containing 50 μg / mL kanamycin and 40 μg / mL streptomycin, and culture at 37°C and 200 rpm for 6-8 hours; take 2 μL of the bacterial solution, and perform colony PCR identification according to the 50 μL PCR reaction system. If the target band appears and the band is single, the colony is a positive clone;

[0105] The ACO gene on the pETDuet-1 plasmid was verified by colony PCR. The primer sequences designed in this experiment are shown in Table 2. The agarose gel electrophoresis of the PCR amplified ACO product is shown in Figure 3 As shown:

[0106] Table 2: Primer sequences

[0107]

[0108] ② Protein expression and solubility identification

[0109] Take 900 μL of the above bacterial solution, add IPTG to the E. coli to a concentration of 0.5 mM, and induce the culture for 20 hours; centrifuge at 12000 rpm for 1 min, collect the cells, add 2 times loading buffer, resuspend the cells, denature in a 100°C water bath for 10 min, and detect protein expression by SDS-PAGE. The results are as follows: Figure 4 As shown, positive clones are shown.

[0110] ③ Bacteria sample sequencing

[0111] The positive clones identified by the above two methods were sent to a sequencing company for sequencing to further prove the correctness of the constructed positive clones.

[0112] Finally, the genetically engineered Escherichia coli was constructed:

[0113] (BL21) / pETDuet-1- Ct ACO2, pET28a-SUMO-YdiI,

[0114] (BL21) / pETDuet-1- Ct ACO4, pET28a-SUMO-YdiI,

[0115] (BL21) / pETDuet-1- Ct ACO5, pET28a-SUMO-YdiI,

[0116] (BL21) / pETDuet-1- Yl ACO, pET28a-SUMO-YdiI.

[0117] Example 4: Construction of genetically engineered yeast Saccharomyces cerevisiae

[0118] (1) Preparation of Saccharomyces cerevisiae competent cells

[0119] ① Pick a single colony of Saccharomyces cerevisiae (or a preserved strain) and inoculate it into 50 mL of liquid YPD medium, and culture it overnight at 30°C and 200 rpm;

[0120] ②Take 1mL of Saccharomyces cerevisiae culture medium and inoculate it into 50mL of liquid YPD medium. Cultivate at 30℃ and 200rpm until the culture OD reaches 600 About 3.0-5.0;

[0121] ③ Dilute 10 mL of YPD overnight culture to OD 600 About 0.2 to 0.4;

[0122] ④ Place the bacterial solution in a 30℃ constant temperature shaker and continue to culture for 3 to 6 hours until its OD 600 Reach about 0.6 to 1.0;

[0123] ⑤ Transfer the bacterial solution to a centrifuge tube and centrifuge at 3700 rpm for 10 min at 4°C to collect the bacteria;

[0124] ⑥ Resuspend the cells in 10 mL of pre-cooled 100 mM PBS buffer (pH 7.4), and centrifuge at 3700 rpm for 10 min at 4°C to collect the cells;

[0125] ⑦ Add 1 mL of TE / LiAc solution to each centrifuge tube, resuspend the bacteria, and obtain competent cells;

[0126] ⑧ Aliquot the competent cells and freeze them at -80℃.

[0127] (2) Transformation of recombinant plasmids in Saccharomyces cerevisiae

[0128] ① Recombinant plasmid pETDuet-1- Ct ACO2 and pESC-URA-SUMO-YdiI are one group, pETDuet-1- Ct ACO4 and pESC-URA-SUMO-YdiI are one group, pETDuet-1- Ct ACO5 and pESC-URA-SUMO-YdiI are one group, pETDuet-1- Yl ACO and pESC-URA-SUMO-YdiI were grouped together. The volume ratio of the two plasmids in each group was 1:1, totaling 2 μL. They were added to 50 μL of freshly prepared competent cells, and 500 μL of transformation solution (PEG / LiAc, DMSO) was added. The cells were gently mixed and placed in an ice bath for 30 min.

[0129] ② Incubate in a 30℃ constant temperature shaker for 1 hour, tapping the tube wall every 15 minutes to mix;

[0130] ③ Add 900 μL of liquid YPD medium and culture at 30°C, 200 rpm with shaking for 60 min;

[0131] ④ Centrifuge at 3700 rpm for 10 min to collect the cells, discard the supernatant, and resuspend the precipitate in 100 μL TE;

[0132] ④ Take 100 μL of the above bacterial solution and spread the Saccharomyces cerevisiae bacterial solution on YPD solid medium with 100 μg / mL ampicillin and 40 μg / mL streptomycin;

[0133] ⑤ Place the YPD solid culture medium upright in a 37℃ incubator for 30 minutes. After the bacterial liquid is absorbed dry, invert the plate and culture at 37℃ for 12-16 hours.

[0134] (3) Identification of positive clones:

[0135] ① Colony PCR identification

[0136] Pick the single colony cultured above, inoculate the brewer's yeast into 1 mL of YPD medium containing 100 μg / mL ampicillin and 40 μg / mL streptomycin, and culture at 30°C and 200 rpm for 6-8 h; draw 2 μL of the bacterial solution, and perform colony PCR identification according to the method of Example 3 in a 50 μL PCR reaction system to verify the ACO gene on the pETDuet-1 plasmid. If the target band appears and the band is single, the colony is a positive clone;

[0137] ② Protein expression and solubility identification

[0138] 900 μL of the above bacterial solution was taken, 2% galactose was added to the cerevisiae, and the culture was induced for 48 hours, centrifuged at 12000 rpm for 1 min, the cells were collected, 2 times the loading buffer was added, the cells were resuspended, and denatured in a 100° C. water bath for 10 min. The protein expression was detected by SDS-PAGE in the manner of Example 3, and positive clones were screened;

[0139] ③ Bacteria sample sequencing

[0140] The positive clones identified by the above two methods were sent to a sequencing company for sequencing to further prove the correctness of the constructed positive clones.

[0141] Finally, the genetically engineered yeast Saccharomyces cerevisiae was constructed:

[0142] Sc. / pETDuet-1- Ct ACO2, pESC-URA-SUMO-YdiI,

[0143] Sc. / pETDuet-1- Ct ACO4, pESC-URA-SUMO-YdiI,

[0144] Sc. / pETDuet-1- Ct ACO5, pESC-URA-SUMO-YdiI,

[0145] Sc. / pETDuet-1- YlACO, pESC-URA-SUMO-YdiI.

[0146] Example 5: Preparation of 10-hydroxy-2-decenoic acid using genetically engineered bacteria

[0147] (1) Bacteria activation:

[0148] The genetically engineered Escherichia coli constructed in Example 3 was inoculated into 50 mL of liquid LB medium containing 50 μg / mL kanamycin and 40 μg / mL streptomycin at an inoculum size of 1%, and cultured at 37° C. and 200 rpm with shaking for 12 h;

[0149] The genetically engineered yeast Saccharomyces cerevisiae constructed in Example 4 was inoculated into 50 mL of liquid YPD medium containing 100 μg / mL ampicillin and 40 μg / mL streptomycin at an inoculum size of 1%, and cultured at 30° C. and 200 rpm with shaking for 12 h;

[0150] (2) Bacteria transfer:

[0151] Take 1 mL of the activated strain of E. coli genetically engineered bacteria and inoculate it into 50 mL of liquid LB medium containing 50 μg / mL kanamycin and 40 μg / mL streptomycin, and culture at 37°C and 200 rpm until the OD of the bacterial solution reaches 600 0.8; after cooling to 16°C for 1 hour, add IPTG to a concentration of 0.5 mM, and continue induction culture at 37°C and 200 rpm for 20 hours;

[0152] Take 1 mL of the activated strain of the above-mentioned genetically engineered Saccharomyces cerevisiae and inoculate it into 50 mL of liquid YPD medium containing 100 μg / mL ampicillin and 40 μg / mL streptomycin, and shake and culture at 30°C and 200 rpm until the OD of the bacterial solution reaches 0. 600 0.8, cooled to 16°C for 1 hour, added 2% galactose, and continued induction culture at 30°C and 200rpm for 48 hours;

[0153] (3) Collecting bacteria: Take 50 mL of the above cultured bacterial solution and centrifuge at 5000 rpm and 4°C for 15 min to collect the bacteria;

[0154] (4) Wash the cells three times with 100 mM PBS buffer (pH 7.2-7.4), resuspend the cells with transformation medium and inoculate the transformation medium; the transformation medium for Escherichia coli comprises 1% glycerol, 0.4% glucose, 50 μg / mL kanamycin and 40 μg / mL streptomycin, and the remainder is 100 mM potassium phosphate buffer at a pH of 7.4, 10-hydroxydecanoic acid is dissolved in dimethyl sulfoxide, and then added to the transformation medium, so that the concentration of 10-hydroxydecanoic acid in the medium is 0.1 g / L, and the reaction is carried out at 37°C for 24 hours to obtain a fermentation broth; the transformation medium for Saccharomyces cerevisiae comprises 1% glycerol, 0.4% glucose, 100 μg / mL ampicillin and 40 μg / mL streptomycin, and the remainder is 100 mM potassium phosphate buffer at a pH of 7.4, 10-hydroxydecanoic acid is dissolved in dimethyl sulfoxide, and then added to the transformation medium, so that the concentration of 10-hydroxydecanoic acid in the medium is 0.1 g / L, and the reaction is carried out at 30°C for 24 hours to obtain a fermentation broth.

[0155] Silanization treatment of fermentation broth: take 1 mL of fermentation broth into a 2 mL centrifuge tube, add 1 mL of 4 M HCl solution, vortex centrifuge, heat at 100 ° C for 10 min, and then refrigerate at -80 ° C for 15 min. After melting at room temperature, add 1 mL of ethyl acetate and vortex centrifuge. Collect the organic phase into a new tube, add 100 μL of N, O-bis (trimethylsilyl) trifluoroacetamide and shake to mix. After 70 ° C water bath for 40 min, set aside.

[0156] Detection of generated products by gas chromatography-mass spectrometry: Gas chromatography-mass spectrometry used helium as carrier gas, constant flow mode, injection volume of 1 μL, split injection, split ratio of 1:50, injection temperature of 250 °C, maintained at 50 °C for 1 min, increased to 250 °C at 15 °C / min, and maintained for 10 min.

[0157] The mass spectrum of the fermentation product 10-hydroxy-2-decenoic acid is shown in Figure 5 shown.

[0158] The yield changes of 10-hydroxy-2-decenoic acid produced by recombinant bacteria fermentation are as follows Figure 6 shown.

[0159] The detected yield of 10-hydroxy-2-decenoic acid and the calculated conversion rate are shown in Table 3:

[0160] Table 3: Production and conversion rate of 10-hydroxy-2-decenoic acid of each genetically engineered bacteria

[0161]

[0162]

[0163] From the above data, it can be seen that the initial host bacteria lacked the key enzyme for the synthesis of 10-hydroxy-2-decenoic acid, so 10-hydroxy-2-decenoic acid could not be synthesized. After the acyl-CoA oxidase gene and the acyl-CoA thioesterase gene were transformed into the host strain, the prepared genetically engineered bacteria could synthesize 10-hydroxy-2-decenoic acid in one step using 10-hydroxydecanoic acid as a substrate. The synthesis pathway is roughly as follows: acyl-CoA oxidase catalyzes 10-hydroxydecanoic acid to synthesize 10-hydroxy-2-decenoyl-CoA, and acyl-CoA thioesterase catalyzes 10-hydroxy-2-decenoyl-CoA to remove CoA and synthesize 10-hydroxy-2-decenoic acid, and the conversion rate is 36-92%. In particular, the genetically engineered Escherichia coli (BL21) / pETDuet-1- Ct ACO2, pET28a-SUMO-YdiI and (BL21) / pETDuet-1- Ct ACO5, pET28a-SUMO-YdiI, the conversion rates were 85% and 92% respectively, and the Saccharomyces cerevisiae genetic engineering strain Sc. / pETDuet-1- Ct ACO2, pESC-URA-SUMO-YdiI and Sc. / pETDuet-1- Ct The conversion rates of ACO5 and pESC-URA-SUMO-YdiI both reached 82%, which was a significant improvement.

Claims

1. An engineered bacterium containing an acyl-CoA oxidase gene, characterized in that: The engineering bacteria include an acyl-CoA oxidase gene and an acyl-CoA thioesterase gene; the nucleotide sequence of the acyl-CoA oxidase gene is SEQ ID NO.1, SEQ ID NO.2, SEQ ID NO.3 or SEQ ID NO.4; the nucleotide sequence of the acyl-CoA thioesterase gene is SEQ ID NO.5; and the host bacteria of the engineering bacteria is Escherichia coli or Saccharomyces cerevisiae.

2. The engineered bacterium containing the acyl-CoA oxidase gene according to claim 1, characterized in that: The acyl-CoA oxidase gene is derived from Candida tropicalis or Yarrowia lipolytica.

3. The engineered bacterium containing the acyl-CoA oxidase gene according to claim 1, characterized in that: The amino acid sequence of the acyl-CoA oxidase is SEQ ID NO.6, SEQ ID NO.7, SEQ ID NO.8 or SEQ ID NO.9, and the amino acid sequence of the acyl-CoA thioesterase is SEQ ID NO.

10.

4. The method for constructing an engineered bacterium containing an acyl-CoA oxidase gene according to claim 1, characterized in that: Here are the steps: (1) Construction of recombinant plasmids pETDuet-1-ACO, pET28a-SUMO-ACOT, and pESC-URA-SUMO-ACOT; The nucleotide sequence of the acyl-CoA oxidase gene is shown in SEQ ID NO.1, SEQ ID NO.2, SEQ ID NO.3 or SEQ ID NO.4, and the nucleotide sequence of the acyl-CoA thioesterase gene is shown in SEQ ID NO.5; (2) transforming the recombinant plasmids pETDuet-1-ACO and pET28a-SUMO-ACOT of step (1) into Escherichia coli, and obtaining genetically engineered Escherichia coli after screening and identification; The recombinant plasmids pETDuet-1-ACO and pESC-URA-SUMO-ACOT of step (1) are co-transformed into Saccharomyces cerevisiae, and after screening and identification, genetically engineered Saccharomyces cerevisiae are obtained.

5. Use of the engineered bacteria containing the acyl-CoA oxidase gene according to claim 1 in preparing 10-hydroxy-2-decenoic acid using 10-hydroxydecanoic acid as a substrate.

6. A method for preparing 10-hydroxy-2-decenoic acid using an engineered bacterium containing an acyl-CoA oxidase gene and 10-hydroxydecanoic acid as a substrate, characterized in that: Here are the steps: The genetically engineered Escherichia coli constructed according to claim 4 is induced to obtain induced cells, the induced cells are inoculated into a transformation medium, 10-hydroxydecanoic acid is added, and fermentation is carried out at 37° C. to obtain 10-hydroxy-2-decenoic acid.

7. The method according to claim 6, characterized in that Meet one or more of the following conditions: i. The induction culture is as follows: the genetically engineered E. coli bacteria are inoculated into a liquid LB medium containing 50 μg / mL kanamycin and 40 μg / mL streptomycin, and cultured at 37°C with shaking until the bacterial solution OD 600 0.8-1.2, cool to 16-20℃, adapt for 1 hour, add IPTG to a concentration of 0.5mM, continue induction culture for 20-25 hours, separate cells, and obtain induced cells; ii. The transformation medium components are as follows, all in mass percentage: Glycerol 1%, glucose 0.4%, kanamycin 50 μg / mL, streptomycin 40 μg / mL, the balance is 100 mM potassium phosphate buffer at pH 7.4; iii. Add 10-hydroxydecanoic acid to a concentration of 0.1 g / L; iv. Dissolve 10-hydroxydecanoic acid in dimethyl sulfoxide and add to the transformation medium.

8. The method according to claim 7, characterized in that The cells were separated in condition i by centrifugation at 5000 rpm for 15 min, the cell pellets were collected, and then the cell pellets were washed with 100 mM PBS buffer at pH 7.2-7.

4.

9. A method for preparing 10-hydroxy-2-decenoic acid using an engineered bacterium containing an acyl-CoA oxidase gene and 10-hydroxydecanoic acid as a substrate, characterized in that: Here are the steps: The genetically engineered yeast of claim 4 is induced to obtain induced cells, the induced cells are inoculated into a transformation medium, 10-hydroxydecanoic acid is added, and fermentation is carried out at 30° C. to obtain 10-hydroxy-2-decenoic acid.

10. The method according to claim 9, characterized in that Meet one or more of the following conditions: i. The induction culture is as follows: the genetically engineered yeast Saccharomyces cerevisiae is inoculated into a liquid YPD medium containing 100 μg / mL ampicillin and 40 μg / mL streptomycin, and the culture is shaken and screened at 30°C until the bacterial solution OD 600 0.8-1.2, cooled to 16-20℃ for 1 hour, added 2% galactose, continued induction culture for 48-55 hours, separated the cells, and obtained induced cells; ii. The transformation medium components are as follows, all in mass percentage: Glycerol 1%, glucose 0.4%, ampicillin 100 μg / mL, streptomycin 40 μg / mL, the balance is 100 mM potassium phosphate buffer at pH 7.4; iii. Add 10-hydroxydecanoic acid to a concentration of 0.1 g / L; iv. Dissolve 10-hydroxydecanoic acid in dimethyl sulfoxide and add to the transformation medium.

11. The method according to claim 10, characterized in that The cells were separated in condition i by centrifugation at 5000 rpm for 15 min, the cell pellets were collected, and then the cell pellets were washed with 100 mM PBS buffer at pH 7.2-7.4.